The stock's fall snapped a two-day winning streak.

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

Shares of Boston Scientific Corp. BSX slipped 1.66% to $99.13 Friday, on what proved to be an all-around great trading ...

Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...

Boston Scientific BSX has witnessed strong momentum in the past year. Shares of the company have risen 42.4% compared with 8.5% growth of the industry during the same time frame. The S&P 500 Composite ...

In the closing of the recent trading day, Boston Scientific (BSX) stood at $95.52, denoting a +1.48% change from the preceding trading day. Boston Scientific (NYSE:BSX) recently experienced a 4% ...

An ambitious start-up embodies new optimism that artificial intelligence can turbocharge scientific discovery.

Boston Scientific’s stock surged 40.6% in the past year, far outpacing the broader market. This growth stems from strong ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy ...

A new biotech is raising money to develop a drug believed to be capable of starving cancer cells, based on research out of a ...

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and ...